Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

US STOCKS-Wall Street ends higher on stimulus optimism, Apple boost

Published 12/16/2020, 05:00 AM
Updated 12/16/2020, 05:10 AM
© Reuters.
US500
-
DJI
-
US2000
-
AAPL
-
IXIC
-
SPLRCD
-
SPLRCU
-
SPLRCT
-
SPLRCM
-
MRNA
-
PRVL
-

(For a live blog on the U.S. stock market, click LIVE/ or
type LIVE/ in a news window)
* Apple jumps on report of higher iPhone production in 2021
* Technology sector seen resilient through pandemic -
analyst
* Utilities and materials sectors among strongest performers


(Updates with close of session)
By Noel Randewich and Karen Pierog
Dec 15 (Reuters) - Wall Street surged on Tuesday, with its
main indexes closing near record levels, helped by optimism
about a potential government stimulus and bets on more signals
of easy monetary policy from the Federal Reserve's final meeting
of the year.
Apple Inc AAPL.O was the top boost to all three U.S.
benchmarks, surging to its highest since September after a
report said it plans to increase iPhone production by 30% in the
first half of 2021. The Russell 2000 index .RUT of smaller companies surged to
a record high.
Some investors viewed the recent spike in coronavirus
infections and deaths and a grim November employment report as
an impetus for a quick deal on a COVID-19 stimulus bill, with
economically sensitive sectors such as consumer discretionary
.SPLRCD , materials .SPLRCM leading gains.
The S&P 500 utilities index .SPLRCU logged its strongest
one-day gain since early November.
"They have lagged, and you could see a little bit of
rotation of people looking for yield," said 6 Meridian Chief
Investment Officer Andrew Mies, referring to utilities stocks.
Broad gains across the stock market were a healthy sign,
Mies added.
U.S. House Speaker Nancy Pelosi invited top congressional
leaders to meet later on Tuesday in an effort to finalize a
massive government spending deal and reach an agreement on a new
package of coronavirus relief. The Fed is also expected to signal low-interest rates for
the foreseeable future in its two-day meeting starting Tuesday.
The recent coronavirus vaccine roll-out is expected to improve
the central bank's 2021 outlook. Unofficially, the Dow Jones Industrial Average .DJI rose
1.14% to end at 30,201.68 points, while the S&P 500 .SPX
gained 1.30% to 3,694.77.
The Nasdaq Composite .IXIC climbed 1.25% to 12,595.06.
Supported by Apple, the S&P 500 technology sector index
.SPLRCT also rallied. The sector has outperformed the broader
market during the pandemic and is up over 35% year to date, with
investors viewing it as resilient to virus-related disruptions.
"The market likes to go to tech when it is afraid the
economy may stall because of a rise in infections and
shutdowns," said Christopher Grisanti, chief equity strategist
at MAI Capital Management.
Increased liquidity and ultra-low lending rates have sent
investors flocking to stocks for during the COVID-19 pandemic,
while recent optimism over a vaccine pushed the S&P 500 to a
series of record highs last week.
"We have prices up and earnings down and we still have a
risk to the economy out there, so that's where the potential
challenge is," warned Mike O'Rourke, chief market strategist at
JonesTrading in Stamford, Connecticut. "Investors have to be
more tactical, look at more of that value space that probably
offers more opportunity as the recovery unfolds."
Eli Lilly and Co LLY.N jumped after the company said it
would buy Prevail Therapeutics Inc PRVL.O in a deal
potentially valued at $1 billion to expand its presence in the
lucrative field of gene therapy. Prevail's shares surged close
to 80%. Moderna Inc's MRNA.O shares tumbled, even after U.S. Food
and Drug Administration staff members did not raise any new
concerns over data on the drugmaker's COVID-19 vaccine. A report
said the vaccine will gain emergency use approval on Friday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.